Skip to main content
Log in

Heterogeneous expression of invasive and metastatic properties in a prostate tumor model

  • Article
  • Published:
Pathology & Oncology Research

Abstract

Cellular heterogeneity of neoplasia is well demonstrated in the Dunning R-3327 rat prostate adenocarcinoma. In this study, we measured the differential expression of invasive and metastatic properties of this prostate model by cloning from a heterogeneous parental cell line. Four cell clones were derived and characterized by morphological studies, E-cadherin expression, and invasive and metastatic potential. Three of the clones (clones 5′A, 5′C, and 5′D) demonstrated a fibroblastic morphology and were anchored to the substrate by loose microvillous processes. The fourth clone (clone 5′B) grew in tight clusters and displayed many closely spaced microvilli, long overlapping cytoplasmic regions with well-defined junctional complexes. The parental line (R3327-5′) demonstrated a combination of both these growth patterns. E-cadherin expression was absent in clones 5′A, 5′C, and 5′D and very prominent in clone 5′B, when compared to the parental line. The absence of E-cadherin expression correlated with increased invasiveness, as measured in an in vitro invasion assay. Subcutaneous injections of clones 5′A, 5′C, and 5′D yielded lung metastases and no primary tumors at the site of inoculation while clone 5′B was tumorigenic and produced fewer lung metastases in vivo. These clones, therefore, provide a potential for studying a variety of molecules involved in prostate cancer invasion and metastasis, especially for the direct testing of the significance of E-cadherin expresssion in prostate cancer progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bao L, Loda M, Janmey PA et al: Thymosin beta 15: A novel regulator of tumor cell motility upregulated in metastatic prostate cancer. Nature Medicine 2(12): 1322–1328, 1996.

    Article  PubMed  CAS  Google Scholar 

  2. Bussemakers MJG, Moorselaar RJA, Giroldi LA et al: Decreased expression of E-cadherin in the progression of rat prostate cancer. Cancer Research 52:2916–2922, 1992.

    PubMed  CAS  Google Scholar 

  3. Cheng L, Nagabhushan M, Pretlow TP et al: Expression of E- cadherin in primary and metastatic prostate cancer. American Journal of Pathology 148(5): 1375–1380, 1996.

    PubMed  CAS  Google Scholar 

  4. Dong JT, Lamb PV, Rinker-Schaeffer CW et al: KAI1, a metas- tasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 268:884–886, 1995.

    Article  PubMed  CAS  Google Scholar 

  5. Dunning WF: Prostate cancer in the rat. Monographs of the National Cancer Institute 12:351–369, 1963.

    CAS  Google Scholar 

  6. Fidler IJ, Hart IR: Biological diversity in metastatic neoplasms: origins and implications. Science 217:998–1003, 1982.

    Article  PubMed  CAS  Google Scholar 

  7. Frixen U, Behrens J, Sachs M et al: E-cadherin mediated cell- cell adhesion prevents invasiveness of human carcinoma cells. Journal of Cell Biology 111:173–185, 1990.

    Google Scholar 

  8. Frixen UH, and Nagamine Y: Stimulation of urokinase-type plasminogen activator expression by blockage of E-cadherin-dependent cell-cell adhesion. Cancer Research 53:3618–3623, 1993.

    PubMed  CAS  Google Scholar 

  9. Gao AC, Lou W, Dong JT, and Isaacs JT: CD44 is a metastasis suppressor gene for prostate cancer located on human chromosome 11p13. Cancer Research 57:846–849, 1997.

    PubMed  CAS  Google Scholar 

  10. Hendrix MJC, Seftor EA, Seftor REB and Fidler IJ: A simple quantitative assay for studying the invasive potential of high and low metastatic variants. Cancer Letters 38:137–147, 1987.

    Article  PubMed  CAS  Google Scholar 

  11. Isaacs JT, Wake N, Coffey DS, and Sandberg AA: Genetic instability coupled to clonal selection as a mechanism for tumor progression in the Dunning R-3327 rat prostatic adenocarcinoma system. Cancer Research 42:2353–2361, 1982.

    PubMed  CAS  Google Scholar 

  12. Isaacs WB, Bova GS, Morton RA et al: Molecular biology of prostate cancer progression. Cancer Surveys 23:19–32, 1995.

    PubMed  CAS  Google Scholar 

  13. Isaacs JT: The R-3327 System of rat prostatic cancers. Urologic Oncology 2(4): 115–116, 1996.

    Google Scholar 

  14. MacCalman CD, Brodt P, Doublet JD et al: The loss of E-cad- herin mRNA transcripts in rat prostatic tumors is accompanied by increased expression of mRNA transcripts encoding fibronectin and its receptor. Clinical & Experimental Metastasis 12(2): 101- 107, 1994.

    Article  CAS  Google Scholar 

  15. Otto T, Birchmier W, Schmidt U et al: Inverse relation of E-cad- herin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas. Cancer Research 54(12):3120–3123, 1994.

    PubMed  CAS  Google Scholar 

  16. Rinker-Schaeffer CW, Partin AW et al: Molecular and cellular changes associated with the acquisition of metastatic ability by prostatic cancer cells. Prostate 25:249–265, 1994.

    Article  PubMed  CAS  Google Scholar 

  17. Ross JS, Figge HL, Bui HX et al: E-cadherin expression in prostatic carcinoma biopsies: Correlation with tumor grade, DNA content, pathological stage, and clinical outcome. Modern Pathology 7(8): 835–841, 1994.

    PubMed  CAS  Google Scholar 

  18. Rowley DR, Feuchter FA, and Heidger PM: Aclar plastic substratum: A cell culture method facilitating preparations for electron microscopy and replicate sampling. Tissue Culture Assn. Man. 5:1067–1069, 1979.

    Article  Google Scholar 

  19. Takeichi M: Cadherins: a molecular family important in selective cell-cell adhesion. Annual Review of Biochemistry 59: 237–252, 1990.

    Article  PubMed  CAS  Google Scholar 

  20. Takeichi M: Cadherins in Cancer: implications for invasion and metastasis. Current Opinion in Cell Biology 5:806–811, 1993.

    Article  PubMed  CAS  Google Scholar 

  21. Thompson SA, Johnson MP, Heidger PM and Lubaroff DM: Characterization of the heterogeneity of R-3327 rat prostatic tumors derived from single-cell clones. The Prostate 6:369–387, 1985.

    Article  PubMed  CAS  Google Scholar 

  22. Umbas R, Isaacs WB, Bringuier PP et al: Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Research 54(14):3929–3933, 1994.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Luo, J., Sharma, N., Seftor, E.A. et al. Heterogeneous expression of invasive and metastatic properties in a prostate tumor model. Pathol. Oncol. Res. 3, 264–271 (1997). https://doi.org/10.1007/BF02904285

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02904285

Key words

Navigation